33
Views
7
CrossRef citations to date
0
Altmetric
Review

Tau protein as a therapeutic target in Alzheimer’s disease and other neurodegenerative disorders

Pages 1359-1370 | Published online: 25 Feb 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (6)

Ana Castro, Arantxa Encinas, Carmen Gil, Stefan Bräse, Williams Porcal, Concepción Pérez, Francisco J. Moreno & Ana Martínez. (2008) Non-ATP competitive glycogen synthase kinase 3β (GSK-3β) inhibitors: Study of structural requirements for thiadiazolidinone derivatives. Bioorganic & Medicinal Chemistry 16:1, pages 495-510.
Crossref
Vipin Kumar & A.K. Madan. (2005) Application of graph theory: prediction of glycogen synthase kinase-3 β inhibitory activity of thiadiazolidinones as potential drugs for the treatment of Alzheimer's disease. European Journal of Pharmaceutical Sciences 24:2-3, pages 213-218.
Crossref
Marie Knockaert, Paul Greengard & Laurent Meijer. (2002) Pharmacological inhibitors of cyclin-dependent kinases. Trends in Pharmacological Sciences 23:9, pages 417-425.
Crossref
Ana Martinez, Mercedes Alonso, Ana Castro, Concepción Pérez & Francisco J. Moreno. (2002) First Non-ATP Competitive Glycogen Synthase Kinase 3 β (GSK-3β) Inhibitors:  Thiadiazolidinones (TDZD) as Potential Drugs for the Treatment of Alzheimer's Disease. Journal of Medicinal Chemistry 45:6, pages 1292-1299.
Crossref
Keshab Bhattacharya, Kenneth B. Rank, David B. Evans & Satish K. Sharma. (2001) Role of Cysteine-291 and Cysteine-322 in the Polymerization of Human Tau into Alzheimer-like Filaments. Biochemical and Biophysical Research Communications 285:1, pages 20-26.
Crossref
Maryse Leost, Christiane Schultz, Andreas Link, Yong‐Zhong Wu, Jacek Biernat, Eva‐Maria Mandelkow, James A. Bibb, Gretchen L. Snyder, Paul Greengard, Daniel W. Zaharevitz, Rick Gussio, Adrian M. Senderowicz, Edward A. Sausville, Conrad Kunick & Laurent Meijer. (2001) Paullones are potent inhibitors of glycogen synthase kinase‐3β and cyclin‐dependent kinase 5/p25. European Journal of Biochemistry 267:19, pages 5983-5994.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.